The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Hepatectomy followed by adjuvant chemotherapy with capecitabine plus oxaliplatin for three months for colorectal cancer liver metastases: A multicenter phase 2 study.
 
Hiroki Hashida
No Relationships to Disclose
 
Hironaga Satake
No Relationships to Disclose
 
Hiroaki Tanioka
No Relationships to Disclose
 
Yasuhiro Miyake
No Relationships to Disclose
 
Shinichi Yoshioka
No Relationships to Disclose
 
Takanori Watanabe
No Relationships to Disclose
 
Masato Matsuura
No Relationships to Disclose
 
Takahisa Kyogoku
No Relationships to Disclose
 
Michio Inukai
No Relationships to Disclose
 
Takeshi Kotake
No Relationships to Disclose
 
Yoshihiro Okita
No Relationships to Disclose
 
Yukimasa Hatachi
No Relationships to Disclose
 
Hisateru Yasui
No Relationships to Disclose
 
Masahito Kotaka
Speakers' Bureau - Chugai Pharma; Merck Serono; Taiho Pharmaceutical; Takeda; Yakult Pharmaceutical
 
Takeshi Kato
Honoraria - Bayer; Chugai Pharma; Lilly; Merck Serono; Taiho Pharmaceutical; Takeda
Consulting or Advisory Role - Chugai Pharma; Takeda
Speakers' Bureau - Bayer; Chugai Pharma; Lilly; Merck Serono; Taiho Pharmaceutical; Takeda
 
Satoshi Kaihara
No Relationships to Disclose
 
Akihito Tsuji
Honoraria - Bristol-Myers Squibb Japan; Chugai Pharma; Daiichi Sankyo; Merck Serono; Taiho Pharmaceutical; Takeda
Speakers' Bureau - Chugai Pharma; Merck Serono; Taiho Pharmaceutical; Takeda